Caption Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Sell |
6,499
-19,501
| -75% | -$3.37M | 0.01% | 222 |
|
|
2025
Q1 | $4.05M | Sell |
26,000
-19,381
| -43% | -$3.02M | 0.04% | 66 |
|
|
2024
Q4 | $6.25M | Buy |
+45,381
| New | +$6.25M | 0.06% | 30 |
|
|
2024
Q3 | – | Sell |
-4,600
| Closed | -$627K | – | 466 |
|
|
2024
Q2 | $627K | Sell |
4,600
-4,826
| -51% | -$658K | 0.01% | 186 |
|
|
2024
Q1 | $1.42M | Buy |
+9,426
| New | +$1.42M | 0.02% | 128 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 470 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 438 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 379 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 386 |
|
|
2022
Q4 | – | Sell |
-24,472
| Closed | -$2.53M | – | 459 |
|
|
2022
Q3 | $2.53M | Buy |
+24,472
| New | +$2.53M | 0.03% | 41 |
|
|
2022
Q2 | – | Sell |
-3,701
| Closed | -$435K | – | 510 |
|
|
2022
Q1 | $435K | Sell |
3,701
-1,899
| -34% | -$223K | 0.01% | 334 |
|
|
2021
Q4 | $753K | Buy |
+5,600
| New | +$753K | 0.01% | 305 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 545 |
|
|
2021
Q2 | – | Sell |
-4,400
| Closed | -$567K | – | 433 |
|
|
2021
Q1 | $567K | Buy |
+4,400
| New | +$567K | 0.01% | 209 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 330 |
|
|
2019
Q4 | – | Sell |
-45,979
| Closed | -$4.43M | – | 307 |
|
|
2019
Q3 | $4.43M | Buy |
+45,979
| New | +$4.43M | 0.23% | 9 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 249 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 212 |
|